<DOC>
	<DOCNO>NCT00216411</DOCNO>
	<brief_summary>The main purpose study assess effect Quality Life two cycle Dysport treatment post-stroke spasticity upper limb . The effect treatment spasticity function also measure .</brief_summary>
	<brief_title>Effects Quality Life Following Dysport Treatment Post-Stroke Spasticity Arm</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>The patient suffer stroke , define World Health Organisation ( WHO ) criterion , least 6 month previously . The patient hemiparetic arm meet minimum score requirement Modified Ashworth Scale . The patient cognitive communication ability participate study . Patients receive botulinum toxin treatment within past 120 day . Contraindication botulinum toxin treatment . Patients receive oral antispasticity medication change dosage medication month prior study entry . Patients previously treat phenol upper limb spasticity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>